NEW YORK, Sept. 04, 2024 (GLOBE NEWSWIRE) -- ANEW MEDICAL, INC. (NASDAQ: WENA), a U.S. biotechnology company, announced that it has two distinct goals for its pioneering cell and gene therapy...
NEW YORK, Aug. 26, 2024 (GLOBE NEWSWIRE) -- ANEW MEDICAL, INC. (NASDAQ: WENA), a leading U.S. biotechnology company pioneering cell and gene-based treatments for aging and age-related diseases...
NEW YORK, Aug. 21, 2024 (GLOBE NEWSWIRE) -- ANEW MEDICAL, INC. (“ANEW” or the “Company”) (Nasdaq: WENA) announced the signing of an exclusive worldwide license agreement with Transfertech...
NEW YORK, Aug. 19, 2024 (GLOBE NEWSWIRE) -- ANEW MEDICAL, INC. (“ANEW” or “the Company”) (NASDAQ: WENA) a U.S.-based biotechnology company focused on developing cell and gene-based treatments...
NEW YORK, Aug. 15, 2024 (GLOBE NEWSWIRE) -- ANEW MEDICAL, INC. (“ANEW” or “the Company”) (NASDAQ: WENA) a U.S. -based biotechnology company focused on developing cell and gene-based treatments...
Melanocortin receptors on neurons in the brain control feeding and weight lossPatented peptide molecules delivered orally as a pill can control feeding disorders and weight loss NEW YORK, Aug...
Patents issued in mainland China protect the Company’s novel secreted Klotho protein and Its gene delivery systemRecent Patents issued in Hong Kong and Shanghai support protection to develop...
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.2551 | -25.2574257426 | 1.01 | 1.25 | 0.7203 | 1166264 | 1.15935065 | CS |
4 | -1.0751 | -58.7486338798 | 1.83 | 5.11 | 0.7203 | 3739982 | 2.36817121 | CS |
12 | -1.0751 | -58.7486338798 | 1.83 | 5.11 | 0.7203 | 3739982 | 2.36817121 | CS |
26 | -1.0751 | -58.7486338798 | 1.83 | 5.11 | 0.7203 | 3739982 | 2.36817121 | CS |
52 | -1.0751 | -58.7486338798 | 1.83 | 5.11 | 0.7203 | 3739982 | 2.36817121 | CS |
156 | -1.0751 | -58.7486338798 | 1.83 | 5.11 | 0.7203 | 3739982 | 2.36817121 | CS |
260 | 0 | 0 | 0 | 0.9 | 0 | 0 | 0 | CS |
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관